Dolby Laboratories (DLB) earnings history
Most recent quarter
- Fiscal period
- Q3 2026
- Period end
- Jun 26, 2026
- EPS actual
- $0.69
- EPS estimate
- $0.67
- EPS surprise
- +2.80%
- Revenue surprise
- −2.23%
- Revenue
- $305.0M
- Revenue estimate
- $312.0M
- Reported
- Jul 30, 2026
Dolby reported fiscal Q3 2026 results on July 30, 2026. EPS was $0.69, 2.80% above the $0.67 estimate. Revenue was $305.0 million, 2.23% below the $312.0 million consensus. Compared with Q3 2025, EPS fell about 12% from $0.78 and revenue about 3% from $315.5 million.
Annual EPS rose in every fiscal year in the table, from $1.80 in 2022 to $2.06 in 2023, $2.91 in 2024 and $4.25 in 2025, an increase of about 136%. Revenue moved less, staying between $1.25 billion and $1.35 billion in each of those years. The first three quarters of fiscal 2026 total $3.12 per share, about 4% below the same period a year earlier. Since fiscal 2023, Q2 has been the strongest quarter each year, and Q2 2026 set the table highs at $1.37 per share and $395.6 million. Dolby beat the EPS estimate in 15 of the last 20 quarters.
Fiscal Q4 results came between November 16 and November 19 in each of the past five years, pointing to mid-November 2026. That report will complete fiscal 2026 and show how the full year compares with the $4.25 per share of fiscal 2025.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Jul 30, 2026 | $0.67 | $0.69 | +2.80% | $305.0M | SEC |
| Q2 2026 | Apr 30, 2026 | $1.33 | $1.37 | +2.72% | $395.6M | SEC |
| Q1 2026 | Jan 29, 2026 | $0.88 | $1.06 | +20.87% | $346.7M | SEC |
| Q4 2025 | Nov 18, 2025 | $0.70 | $0.99 | +41.59% | $307.0M | SEC |
| Q3 2025 | Jul 31, 2025 | $0.71 | $0.78 | +9.24% | $315.5M | SEC |
| Q2 2025 | May 1, 2025 | $1.27 | $1.34 | +5.74% | $369.6M | SEC |
| Q1 2025 | Jan 29, 2025 | $1.12 | $1.14 | +2.00% | $357.0M | SEC |
| Q4 2024 | Nov 19, 2024 | $0.45 | $0.81 | +82.02% | $304.8M | SEC |
| Q3 2024 | Aug 7, 2024 | $0.31 | $0.40 | +31.15% | $288.8M | SEC |
| Q2 2024 | May 2, 2024 | $1.01 | $1.01 | +0.08% | $364.5M | SEC |
| Q1 2024 | Feb 1, 2024 | $0.53 | $0.69 | +29.97% | $315.6M | SEC |
| Q4 2023 | Nov 16, 2023 | $0.22 | $0.09 | −59.37% | $290.6M | SEC |
| Q3 2023 | Aug 3, 2023 | $0.28 | $0.17 | −38.80% | $298.4M | SEC |
| Q2 2023 | May 4, 2023 | $0.68 | $0.98 | +44.56% | $375.9M | SEC |
| Q1 2023 | Feb 2, 2023 | $0.48 | $0.82 | +69.11% | $334.9M | SEC |
| Q4 2022 | Nov 17, 2022 | $0.41 | $0.28 | −30.86% | $278.2M | — |
| Q3 2022 | Aug 9, 2022 | $0.35 | $0.39 | +10.51% | $289.6M | — |
| Q2 2022 | May 5, 2022 | $0.52 | $0.36 | −31.21% | $334.4M | — |
| Q1 2022 | Feb 3, 2022 | $0.80 | $0.77 | −3.16% | $351.6M | — |
| Q4 2021 | Nov 16, 2021 | $0.35 | $0.42 | +19.15% | $285.0M | — |
Quarterly revenue
Frequently asked questions
When did Dolby Laboratories (DLB) last report earnings?
Dolby Laboratories last reported on Jul 30, 2026, covering fiscal Q3 2026.
Did DLB beat earnings estimates?
Yes. Dolby Laboratories reported EPS of $0.69 for Q3 2026 against a $0.67 estimate — a 2.80% beat.
How much revenue did DLB report last quarter?
Dolby Laboratories reported $305.0M in revenue for Q3 2026, against a consensus estimate of $312.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.